結果ページ2 国：ドイツ セクター：医療 産業：バイオテクノロジー 株式市場―見積もりと価格
価格、時価総額、PE、EPSを含む全株式と自己資本のリスト
ドイツ (443)
- {{country.name}}
- すべての国
- 米国 (646)
- オーストラリア (44)
- オーストリア (11)
- ベルギー (7)
- ブラジル (13)
- カナダ (47)
- 中国 (89)
- デンマーク (6)
- フィンランド (3)
- フランス (26)
- ドイツ (443)
- 香港 (45)
- インド (21)
- イスラエル (13)
- イタリア (3)
- 日本 (37)
- メキシコ (26)
- オランダ (3)
- ニュージーランド (1)
- ノルウェー (10)
- ポーランド (8)
- ロシア (1)
- 韓国 (79)
- スペイン (3)
- スウェーデン (58)
- スイス (10)
- 台湾 (60)
- タイ (2)
- トルコ (1)
- イギリス (25)
全取引所
- {{item.name}}
- 全取引所
- Dusseldorf (1)
- Frankfurt (389)
- Hamburg (1)
- Munich (16)
- Stuttgart (21)
- XETRA (15)
バイオテクノロジー (443)
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 | 予測 |
|---|
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 | 予測 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
|
|
IDEAYA Biosciences, Inc.
30J.SG
DE
|
€23.78 27.45 USD |
0
|
€2.25B 2.6B USD | €0.00 0 USD | €23.76 27.43 USD | €23.89 27.58 USD | €2.25B 2.6B USD | 0 | -€1.36 -1.5 USD | ||
|
IDEAYA Biosciences, Inc.
30J.F
DE
|
€23.75 27.42 USD |
-1.62
|
€2.25B 2.59B USD | €300.00 346.3 USD | €23.75 27.42 USD | €23.75 27.42 USD | €2.25B 2.59B USD | 0 | -€1.36 -1.5 USD | ||
BioArctic AB (publ)
B9A.F
DE
|
€25.12 29 USD |
-2.48
|
€2.23B 2.57B USD | €33.00 38.09 USD | €25.12 29 USD | €25.12 29 USD | €2.23B 2.57B USD | 114.18 | €0.22 0.25 USD | ||
|
Celldex Therapeutics, Inc.
TCE2.F
DE
|
€25.05 28.92 USD |
-0.79
|
€1.97B 2.27B USD | €200.00 230.87 USD | €25.05 28.92 USD | €25.05 28.92 USD | €1.97B 2.27B USD | 0 | -€3.71 -4.2 USD | ||
Ultragenyx Pharmaceutical Inc.
UP0.F
DE
|
€19.76 22.81 USD |
+2.09
|
€1.95B 2.25B USD | €229.00 264.34 USD | €19.76 22.81 USD | €19.76 22.81 USD | €1.95B 2.25B USD | 0 | -€5.29 -6.1 USD | ||
Pharvaris N.V.
9EN.F
DE
|
€26.50 30.59 USD |
-2.39
|
€1.85B 2.14B USD | €300.00 346.3 USD | €26.50 30.59 USD | €26.90 31.05 USD | €1.85B 2.14B USD | 0 | -€2.72 -3.1 USD | ||
Bavarian Nordic A/S
BV3.F
DE
|
€24.22 27.96 USD |
+0.92
|
€1.85B 2.14B USD | €50.00 57.72 USD | €23.82 27.5 USD | €24.22 27.96 USD | €1.85B 2.14B USD | 11.87 | €2.04 2.35 USD | ||
|
BAVARIAN NORDIC N
BV3.DE
DE
|
€24.22 27.96 USD |
+0.25
|
€1.85B 2.14B USD | €2.00 2.31 USD | €24.22 27.96 USD | €24.22 27.96 USD | €1.85B 2.14B USD | 11.87 | €2.04 2.35 USD | ||
|
Aurinia Pharmaceuticals Inc.
IKAP.F
DE
|
€13.25 15.29 USD |
-1.23
|
€1.70B 1.97B USD | €530.00 611.8 USD | €13.25 15.29 USD | €13.25 15.29 USD | €1.70B 1.97B USD | 7.08 | €1.87 2.16 USD | ||
Kodiak Sciences Inc.
K27.F
DE
|
€26.89 31.04 USD |
+1.17
|
€1.68B 1.94B USD | €30.00 34.63 USD | €26.89 31.04 USD | €26.89 31.04 USD | €1.68B 1.94B USD | 0 | -€3.62 -4.1 USD | ||
|
Vericel Corporation
ATQP.F
DE
|
€32.20 37.17 USD |
+1.26
|
€1.64B 1.9B USD | €100.00 115.43 USD | €32.20 37.17 USD | €32.20 37.17 USD | €1.64B 1.9B USD | 87.02 | €0.37 0.43 USD | ||
|
Lakefront Biotherapeutics NV
GXE.DE
DE
|
€24.78 28.6 USD |
+0.57
|
€1.63B 1.88B USD | €12.00 13.85 USD | €24.78 28.6 USD | €24.78 28.6 USD | €1.63B 1.88B USD | 3.34 | €7.41 8.55 USD | ||
|
Lakefront Biotherapeutics NV
GXEA.F
DE
|
€24.60 28.4 USD |
+1.65
|
€1.62B 1.87B USD | €86.00 99.27 USD | €24.60 28.4 USD | €24.60 28.4 USD | €1.62B 1.87B USD | 3.31 | €7.41 8.55 USD | ||
Maravai LifeSciences Holdings, Inc.
MAR.F
DE
|
€4.38 5.06 USD |
+0.46
|
€1.62B 1.87B USD | €2.00K 2.31K USD | €4.28 4.94 USD | €4.38 5.06 USD | €1.62B 1.87B USD | 0 | -€0.62 -0.7 USD | ||
|
Lakefront Biotherapeutics NV
GXE.F
DE
|
€24.44 28.21 USD |
0
|
€1.61B 1.86B USD | €500.00 577.17 USD | €24.44 28.21 USD | €24.44 28.21 USD | €1.61B 1.86B USD | 3.29 | €7.41 8.55 USD | ||
Ocular Therapeutix, Inc.
0OT.F
DE
|
€7.35 8.48 USD |
+1.38
|
€1.61B 1.86B USD | €2.00K 2.31K USD | €7.35 8.48 USD | €7.35 8.48 USD | €1.61B 1.86B USD | 0 | -€1.25 -1.4 USD | ||
|
Zai Lab Limited
1ZL.F
DE
|
€14.20 16.39 USD |
+3.65
|
€1.60B 1.84B USD | €420.00 484.82 USD | €14.20 16.39 USD | €14.20 16.39 USD | €1.60B 1.84B USD | 0 | -€1.48 -1.7 USD | ||
|
Genus plc
GBE.F
DE
|
€24.00 27.7 USD |
0
|
€1.59B 1.84B USD | €3.00 3.46 USD | €24.00 27.7 USD | €24.00 27.7 USD | €1.59B 1.84B USD | 29.26 | €0.82 0.95 USD | ||
|
Biotest AG
BIO.HM
DE
|
€40.00 46.17 USD |
+2.04
|
€1.58B 1.83B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €1.58B 1.83B USD | 0 | -€0.63 -0.7 USD | ||
|
Mesoblast Limited
LWB.F
DE
|
€1.19 1.37 USD |
-1.94
|
€1.54B 1.77B USD | €1.50K 1.73K USD | €1.19 1.37 USD | €1.20 1.38 USD | €1.54B 1.77B USD | 0 | -€0.06 -0.06 USD | ||
|
Stoke Therapeutics, Inc.
0GT.F
DE
|
€24.38 28.14 USD |
-4.65
|
€1.52B 1.75B USD | €606.00 699.53 USD | €24.38 28.14 USD | €24.38 28.14 USD | €1.52B 1.75B USD | 0 | -€2.48 -2.8 USD | ||
|
Viridian Therapeutics, Inc.
1S1.F
DE
|
€13.70 15.81 USD |
-2.14
|
€1.51B 1.75B USD | €2.09K 2.41K USD | €13.70 15.81 USD | €13.70 15.81 USD | €1.51B 1.75B USD | 0 | -€2.91 -3.3 USD | ||
|
Intellia Therapeutics, Inc.
38I.F
DE
|
€10.60 12.24 USD |
-7.02
|
€1.48B 1.71B USD | €500.00 577.17 USD | €10.28 11.87 USD | €10.60 12.24 USD | €1.48B 1.71B USD | 0 | -€3.06 -3.5 USD | ||
Agios Pharmaceuticals, Inc.
8AP.F
DE
|
€24.80 28.63 USD |
+3.33
|
€1.47B 1.7B USD | €180.00 207.78 USD | €24.80 28.63 USD | €24.80 28.63 USD | €1.47B 1.7B USD | 0 | -€6.30 -7.2 USD | ||
|
Iovance Biotherapeutics, Inc.
2LB.F
DE
|
€3.29 3.79 USD |
-1.2
|
€1.47B 1.69B USD | €1.00K 1.15K USD | €3.29 3.79 USD | €3.29 3.79 USD | €1.47B 1.69B USD | 0 | -€0.80 -0.9 USD | ||
|
uniQure N.V.
UQ1.F
DE
|
€23.20 26.78 USD |
+2.65
|
€1.46B 1.69B USD | €250.00 288.58 USD | €23.20 26.78 USD | €23.20 26.78 USD | €1.46B 1.69B USD | 0 | -€3.03 -3.4 USD | ||
Innoviva, Inc.
HVE.F
DE
|
€19.80 22.86 USD |
+2.59
|
€1.46B 1.69B USD | €207.00 238.95 USD | €19.80 22.86 USD | €19.80 22.86 USD | €1.46B 1.69B USD | 3.64 | €5.43 6.27 USD | ||
Pharma Mar, S.A.
PMRA.F
DE
|
€83.10 95.93 USD |
-0.89
|
€1.45B 1.67B USD | €112.00 129.29 USD | €83.10 95.93 USD | €83.10 95.93 USD | €1.45B 1.67B USD | 18.02 | €4.61 5.32 USD | ||
|
Nanobiotix S.A.
5NRA.F
DE
|
€27.60 31.86 USD |
-2.82
|
€1.40B 1.62B USD | €59.00 68.11 USD | €27.60 31.86 USD | €28.20 32.55 USD | €1.40B 1.62B USD | 0 | -€0.50 -0.5 USD | ||
Sarepta Therapeutics, Inc.
AB3A.F
DE
|
€13.06 15.08 USD |
-4.53
|
€1.38B 1.59B USD | €75.00 86.58 USD | €13.06 15.08 USD | €13.06 15.08 USD | €1.38B 1.59B USD | 43.53 | €0.30 0.35 USD | ||
Ascentage Pharma Group International
36X.F
DE
|
€3.68 4.25 USD |
-1.6
|
€1.37B 1.59B USD | €21.00 24.24 USD | €3.68 4.25 USD | €3.68 4.25 USD | €1.37B 1.59B USD | 0 | -€0.45 -0.5 USD | ||
|
AbCellera Biologics Inc.
8QQ.F
DE
|
€4.49 5.18 USD |
+1.7
|
€1.37B 1.58B USD | €390.00 450.19 USD | €4.25 4.9 USD | €4.49 5.18 USD | €1.37B 1.58B USD | 0 | -€0.42 -0.4 USD | ||
|
Nanobiotix S.A.
5NR.F
DE
|
€26.96 31.12 USD |
-2.88
|
€1.37B 1.58B USD | €345.00 398.25 USD | €26.62 30.73 USD | €27.68 31.95 USD | €1.37B 1.58B USD | 0 | -€0.50 -0.5 USD | ||
|
Syndax Pharmaceuticals, Inc.
1T3.F
DE
|
€15.19 17.53 USD |
+0.4
|
€1.35B 1.55B USD | €913.00 1.05K USD | €15.19 17.53 USD | €15.19 17.53 USD | €1.35B 1.55B USD | 0 | -€2.42 -2.7 USD | ||
|
Oxford Nanopore Technologies plc
4R0.F
DE
|
€1.37 1.58 USD |
-4.06
|
€1.33B 1.54B USD | €200.00 230.87 USD | €1.37 1.58 USD | €1.50 1.74 USD | €1.33B 1.54B USD | 0 | -€0.17 -0.1 USD | ||
|
AtaiBeckley Inc.
9VC.F
DE
|
€3.55 4.09 USD |
0
|
€1.29B 1.49B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €1.29B 1.49B USD | 0 | €0.00 0 USD | ||
|
AtaiBeckley Inc.
9VC.DE
DE
|
€3.43 3.95 USD |
0
|
€1.27B 1.47B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €1.27B 1.47B USD | 0 | €0.00 0 USD | ||
|
Palvella Therapeutics Inc. R
PI6.F
DE
|
€88.00 101.58 USD |
-2.22
|
€1.26B 1.46B USD | €6.00 6.93 USD | €88.00 101.58 USD | €88.00 101.58 USD | €1.26B 1.46B USD | 0 | -€3.62 -4.1 USD | ||
Capricor Therapeutics, Inc.
4LN2.F
DE
|
€21.35 24.65 USD |
-2.64
|
€1.24B 1.43B USD | €2.00K 2.31K USD | €21.35 24.65 USD | €21.79 25.15 USD | €1.24B 1.43B USD | 0 | -€2.01 -2.3 USD | ||
|
SELLAS Life Sciences Group, Inc.
RXK3.F
DE
|
€6.16 7.11 USD |
-5.81
|
€1.21B 1.4B USD | €4.14K 4.78K USD | €6.16 7.11 USD | €6.16 7.11 USD | €1.21B 1.4B USD | 0 | -€0.20 -0.2 USD | ||
|
Immunocore Holdings plc
6YG.F
DE
|
€23.80 27.47 USD |
0
|
€1.21B 1.4B USD | €4.00 4.62 USD | €23.80 27.47 USD | €23.80 27.47 USD | €1.21B 1.4B USD | 0 | -€0.49 -0.5 USD | ||
KalVista Pharmaceuticals, Inc.
4XC1.F
DE
|
€22.73 26.24 USD |
0
|
€1.21B 1.4B USD | €300.00 346.3 USD | €22.73 26.24 USD | €22.73 26.24 USD | €1.21B 1.4B USD | 0 | -€3.42 -3.9 USD | ||
|
Precigen, Inc.
I5X.F
DE
|
€3.38 3.9 USD |
+6.96
|
€1.21B 1.39B USD | €500.00 577.17 USD | €3.38 3.9 USD | €3.38 3.9 USD | €1.21B 1.39B USD | 0 | -€1.05 -1.2 USD | ||
|
GH Research PLC
1KA.F
DE
|
€17.30 19.97 USD |
-1.7
|
€1.19B 1.37B USD | €400.00 461.73 USD | €17.30 19.97 USD | €17.30 19.97 USD | €1.19B 1.37B USD | 0 | -€0.79 -0.9 USD | ||
|
Ardelyx, Inc.
41X.F
DE
|
€4.80 5.54 USD |
+0.31
|
€1.19B 1.37B USD | €2.55K 2.94K USD | €4.80 5.54 USD | €4.80 5.54 USD | €1.19B 1.37B USD | 0 | -€0.21 -0.2 USD | ||
|
UroGen Pharma Ltd.
UR8.F
DE
|
€23.75 27.42 USD |
-0.17
|
€1.16B 1.34B USD | €65.00 75.03 USD | €23.75 27.42 USD | €23.75 27.42 USD | €1.16B 1.34B USD | 0 | -€2.38 -2.7 USD | ||
|
Ascletis Pharma Inc.
2VJ.F
DE
|
€1.09 1.26 USD |
-0.91
|
€1.15B 1.33B USD | €700.00 808.03 USD | €1.09 1.26 USD | €1.10 1.27 USD | €1.15B 1.33B USD | 0 | -€0.05 -0.05 USD | ||
Immatics N.V.
4A3.F
DE
|
€7.78 8.98 USD |
-0.7
|
€1.06B 1.23B USD | €450.00 519.45 USD | €7.59 8.76 USD | €7.78 8.98 USD | €1.06B 1.23B USD | 0 | -€1.71 -1.9 USD | ||
|
Everest Medicines Limited
6HN.F
DE
|
€2.88 3.32 USD |
-1.37
|
€1.01B 1.17B USD | €101.00 116.59 USD | €2.88 3.32 USD | €2.88 3.32 USD | €1.01B 1.17B USD | 0 | -€0.11 -0.1 USD | ||
MannKind Corporation
NNFN.F
DE
|
€3.08 3.56 USD |
+0.39
|
€951.88M 1.1B USD | €10.00 11.54 USD | €3.08 3.56 USD | €3.08 3.56 USD | €951.88M 1.1B USD | 0 | -€0.06 -0.06 USD | ||
MedinCell S.A.
MEB.F
DE
|
€26.32 30.38 USD |
+0.61
|
€945.07M 1.09B USD | €285.00 328.99 USD | €25.64 29.6 USD | €26.32 30.38 USD | €945.07M 1.09B USD | 0 | -€0.61 -0.7 USD | ||
|
HBM Holdings Limited
6XY.F
DE
|
€1.07 1.24 USD |
0
|
€893.73M 1.03B USD | €2.88K 3.32K USD | €1.06 1.22 USD | €1.07 1.24 USD | €893.73M 1.03B USD | 10.70 | €0.10 0.12 USD | ||
|
CureVac N.V.
5CV.F
DE
|
€3.91 4.51 USD |
0
|
€885.32M 1.02B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €885.32M 1.02B USD | 0 | €0.00 0 USD | ||
|
Wave Life Sciences Ltd.
1U5.F
DE
|
€4.60 5.31 USD |
-1.71
|
€885.05M 1.02B USD | €50.00 57.72 USD | €4.60 5.31 USD | €4.60 5.31 USD | €885.05M 1.02B USD | 0 | -€0.91 -1.05 USD | ||
Savara Inc.
YB4P.F
DE
|
€4.32 4.98 USD |
+3.73
|
€884.26M 1.02B USD | €1.00K 1.15K USD | €4.32 4.98 USD | €4.32 4.98 USD | €884.26M 1.02B USD | 0 | -€0.49 -0.5 USD | ||
|
Lexicon Pharmaceuticals, Inc.
LX31.MU
DE
|
€3.53 4.07 USD |
0
|
€864.59M 998.02M USD | €250.00 288.58 USD | €3.53 4.07 USD | €3.53 4.08 USD | €864.59M 998.02M USD | 0 | -€0.55 -0.6 USD | ||
|
EyePoint, Inc.
PV3B.F
DE
|
€10.30 11.89 USD |
+5.1
|
€863.57M 996.84M USD | €70.00 80.8 USD | €10.30 11.89 USD | €10.40 12.01 USD | €863.57M 996.84M USD | 0 | -€3.05 -3.5 USD | ||
Oxford Biomedica plc
OXOA.F
DE
|
€6.70 7.73 USD |
-1.47
|
€810.76M 935.89M USD | €1.77K 2.05K USD | €6.70 7.73 USD | €6.70 7.73 USD | €810.76M 935.89M USD | 0 | -€0.31 -0.3 USD | ||
DBV Technologies S.A.
DBV.F
DE
|
€2.68 3.09 USD |
+0.3
|
€792.51M 914.82M USD | €200.00 230.87 USD | €2.68 3.09 USD | €2.68 3.09 USD | €792.51M 914.82M USD | 0 | -€0.78 -0.9 USD | ||
|
GNI Group Ltd.
3G6.F
DE
|
€14.10 16.28 USD |
-2.08
|
€786.13M 907.46M USD | €1.00 1.15 USD | €14.10 16.28 USD | €14.10 16.28 USD | €786.13M 907.46M USD | 0 | -€0.44 -0.5 USD | ||
|
Corvus Pharmaceuticals, Inc.
C17.F
DE
|
€9.30 10.74 USD |
-6.21
|
€782.04M 902.74M USD | €3.00 3.46 USD | €9.30 10.74 USD | €9.30 10.74 USD | €782.04M 902.74M USD | 0 | -€0.48 -0.5 USD | ||
Pharming Group N.V.
PHG.F
DE
|
€10.40 12.01 USD |
0
|
€777.30M 897.26M USD | €181.00 208.93 USD | €10.10 11.66 USD | €10.40 12.01 USD | €777.30M 897.26M USD | 61.17 | €0.17 0.2 USD | ||
Pharming Group N.V.
PHGN.F
DE
|
€1.07 1.24 USD |
-1.25
|
€766.83M 885.18M USD | €2.09K 2.41K USD | €1.07 1.24 USD | €1.07 1.24 USD | €766.83M 885.18M USD | 53.52 | €0.02 0.02 USD | ||
CStone Pharmaceuticals
PH4.F
DE
|
€0.47 0.55 USD |
+3.57
|
€756.27M 872.99M USD | €661.00 763.02 USD | €0.47 0.55 USD | €0.49 0.56 USD | €756.27M 872.99M USD | 0 | -€0.04 -0.04 USD | ||
Alphamab Oncology
3NK.F
DE
|
€0.78 0.89 USD |
+9.93
|
€750.71M 866.57M USD | €2.60K 3K USD | €0.78 0.89 USD | €0.78 0.89 USD | €750.71M 866.57M USD | 0 | -€0.02 -0.02 USD | ||
|
Xencor, Inc.
XE9.F
DE
|
€9.95 11.49 USD |
+1.02
|
€737.71M 851.56M USD | €114.00 131.59 USD | €9.95 11.49 USD | €9.95 11.49 USD | €737.71M 851.56M USD | 0 | -€1.99 -2.2 USD | ||
Theravance Biopharma, Inc.
0TB.F
DE
|
€14.00 16.16 USD |
-0.71
|
€721.74M 833.13M USD | €460.00 530.99 USD | €14.00 16.16 USD | €14.00 16.16 USD | €721.74M 833.13M USD | 7.21 | €1.94 2.24 USD | ||
Takara Bio Inc.
TF2.F
DE
|
€5.95 6.87 USD |
0
|
€716.47M 827.05M USD | €291.00 335.91 USD | €5.95 6.87 USD | €5.95 6.87 USD | €716.47M 827.05M USD | 0 | -€0.43 -0.4 USD | ||
|
Abbisko Cayman Limited
8ZD.F
DE
|
€0.99 1.14 USD |
+3.66
|
€709.09M 818.53M USD | €14.00 16.16 USD | €0.98 1.13 USD | €0.99 1.14 USD | €709.09M 818.53M USD | 99.00 | €0.01 0.01 USD | ||
|
CK Life Sciences Int'l., (Holdings) Inc.
LSI.F
DE
|
€0.07 0.08 USD |
-2.68
|
€696.80M 804.34M USD | €1.62K 1.87K USD | €0.07 0.08 USD | €0.07 0.08 USD | €696.80M 804.34M USD | 0 | €0.00 0 USD | ||
|
Arbutus Biopharma Corporation
I9DN.F
DE
|
€3.51 4.05 USD |
-2.77
|
€693.36M 800.37M USD | €500.00 577.17 USD | €3.51 4.05 USD | €3.51 4.05 USD | €693.36M 800.37M USD | 4.87 | €0.72 0.83 USD | ||
Zevra Therapeutics, Inc.
1GDA.F
DE
|
€11.65 13.45 USD |
+0.43
|
€688.69M 794.98M USD | €65.00 75.03 USD | €11.65 13.45 USD | €11.65 13.45 USD | €688.69M 794.98M USD | 6.69 | €1.74 2.01 USD | ||
|
ORIC Pharmaceuticals, Inc.
4TZ.F
DE
|
€6.44 7.44 USD |
-5.18
|
€666.86M 769.78M USD | €700.00 808.03 USD | €6.44 7.44 USD | €6.44 7.44 USD | €666.86M 769.78M USD | 0 | -€1.21 -1.3 USD | ||
Inventiva S.A.
6IV.F
DE
|
€3.14 3.62 USD |
-6.55
|
€656.10M 757.35M USD | €300.00 346.3 USD | €3.14 3.62 USD | €3.14 3.62 USD | €656.10M 757.35M USD | 0 | -€1.90 -2.1 USD | ||
|
Inventiva S.A.
6IVA.F
DE
|
€3.10 3.58 USD |
+1.97
|
€647.74M 747.71M USD | €929.00 1.07K USD | €3.04 3.51 USD | €3.10 3.58 USD | €647.74M 747.71M USD | 0 | -€1.90 -2.1 USD | ||
Omeros Corporation
3O8.F
DE
|
€8.72 10.07 USD |
+1.4
|
€631.11M 728.52M USD | €1.56K 1.8K USD | €8.72 10.07 USD | €8.72 10.07 USD | €631.11M 728.52M USD | 8.80 | €0.99 1.14 USD | ||
Geron Corporation
GON.F
DE
|
€0.98 1.13 USD |
-0.2
|
€625.48M 722.02M USD | €2.00K 2.31K USD | €0.95 1.1 USD | €0.98 1.13 USD | €625.48M 722.02M USD | 0 | -€0.10 -0.1 USD | ||
Replimune Group, Inc.
7R8.F
DE
|
€7.19 8.3 USD |
-6.07
|
€593.37M 684.94M USD | €747.00 862.29 USD | €7.19 8.3 USD | €7.25 8.37 USD | €593.37M 684.94M USD | 0 | -€2.99 -3.4 USD | ||
|
Avalo Therapeutics Inc. R
C6K0.F
DE
|
€11.26 13 USD |
+2.74
|
€591.89M 683.24M USD | €12.00 13.85 USD | €11.26 13 USD | €11.26 13 USD | €591.89M 683.24M USD | 0 | -€4.83 -5.5 USD | ||
CorMedix Inc.
19KA.F
DE
|
€7.42 8.57 USD |
+1.95
|
€582.27M 672.13M USD | €500.00 577.17 USD | €7.42 8.57 USD | €7.42 8.57 USD | €582.27M 672.13M USD | 3.94 | €1.88 2.17 USD | ||
|
CytomX Therapeutics, Inc.
6C1.F
DE
|
€2.46 2.84 USD |
-2.92
|
€535.11M 617.7M USD | €6.96K 8.04K USD | €2.46 2.84 USD | €2.46 2.84 USD | €535.11M 617.7M USD | 0 | -€0.45 -0.5 USD | ||
|
Opthea Limited
UKJ2.F
DE
|
€3.00 3.46 USD |
0
|
€512.99M 592.16M USD | €0.00 0 USD | €3.00 3.46 USD | €3.00 3.46 USD | €512.99M 592.16M USD | 0 | -€1.94 -2.2 USD | ||
|
Achieve Life Sciences, Inc.
SP4P.F
DE
|
€4.90 5.66 USD |
+2.51
|
€503.03M 580.66M USD | €1.18K 1.36K USD | €4.90 5.66 USD | €4.90 5.66 USD | €503.03M 580.66M USD | 0 | -€0.93 -1.07 USD | ||
|
Aclaris Therapeutics, Inc.
8AT.F
DE
|
€3.53 4.07 USD |
-4.13
|
€493.01M 569.1M USD | €500.00 577.17 USD | €3.53 4.07 USD | €3.53 4.07 USD | €493.01M 569.1M USD | 0 | -€0.49 -0.5 USD | ||
|
Nxera Pharma Co., Ltd.
JSS.F
DE
|
€5.20 6 USD |
+0.97
|
€477.00M 550.62M USD | €5.00 5.77 USD | €5.20 6 USD | €5.20 6 USD | €477.00M 550.62M USD | 0 | -€0.75 -0.8 USD | ||
|
XOMA Royalty Corporation
X0M1.F
DE
|
€35.60 41.09 USD |
+1.71
|
€446.46M 515.36M USD | €22.00 25.4 USD | €35.60 41.09 USD | €35.80 41.33 USD | €446.46M 515.36M USD | 26.17 | €1.36 1.57 USD | ||
|
Laekna, Inc.
4U4.F
DE
|
€0.99 1.14 USD |
+0.51
|
€444.84M 513.49M USD | €3.00 3.46 USD | €0.97 1.11 USD | €0.99 1.14 USD | €444.84M 513.49M USD | 0 | -€0.08 -0.09 USD | ||
|
Genfit S.A.
XUP.SG
DE
|
€8.68 10.02 USD |
+3.33
|
€434.84M 501.95M USD | €965.00 1.11K USD | €8.40 9.7 USD | €8.75 10.1 USD | €434.84M 501.95M USD | 0 | -€1.72 -1.9 USD | ||
Altimmune, Inc.
3G0.F
DE
|
€2.22 2.56 USD |
-0.89
|
€430.76M 497.24M USD | €850.00 981.18 USD | €2.22 2.56 USD | €2.22 2.56 USD | €430.76M 497.24M USD | 0 | -€0.80 -0.9 USD | ||
Ocumension Therapeutics
5DG.F
DE
|
€0.54 0.62 USD |
-0.93
|
€430.10M 496.48M USD | €42.00 48.48 USD | €0.54 0.62 USD | €0.54 0.62 USD | €430.10M 496.48M USD | 0 | -€0.03 -0.03 USD | ||
|
Genfit S.A.
XUP.F
DE
|
€8.41 9.71 USD |
-0.59
|
€421.31M 486.33M USD | €410.00 473.28 USD | €8.41 9.71 USD | €8.41 9.71 USD | €421.31M 486.33M USD | 0 | -€1.72 -1.9 USD | ||
Valneva SE
AYJ0.F
DE
|
€4.34 5.01 USD |
-1.36
|
€411.53M 475.05M USD | €6.12K 7.06K USD | €3.96 4.57 USD | €4.42 5.1 USD | €411.53M 475.05M USD | 0 | -€1.60 -1.8 USD | ||
|
Shanghai Haohai Biological Technology Co., Ltd.
5HB.F
DE
|
€1.78 2.05 USD |
-2.2
|
€400.47M 462.28M USD | €32.00 36.94 USD | €1.78 2.05 USD | €1.81 2.09 USD | €400.47M 462.28M USD | 12.71 | €0.14 0.16 USD | ||
Ovid Therapeutics Inc.
1OT.F
DE
|
€1.94 2.24 USD |
-4.9
|
€362.08M 417.96M USD | €1.10K 1.27K USD | €1.94 2.24 USD | €1.94 2.24 USD | €362.08M 417.96M USD | 0 | -€0.18 -0.2 USD | ||
Avacta Group Plc
RTQ1.F
DE
|
€0.78 0.89 USD |
-3.13
|
€352.71M 407.15M USD | €1.08K 1.24K USD | €0.78 0.89 USD | €0.78 0.89 USD | €352.71M 407.15M USD | 0 | -€0.11 -0.1 USD | ||
|
Prothena Corporation plc
0PT.F
DE
|
€6.73 7.77 USD |
-5.39
|
€352.55M 406.96M USD | €1.50K 1.73K USD | €6.73 7.77 USD | €6.73 7.77 USD | €352.55M 406.96M USD | 0 | -€2.44 -2.8 USD | ||
|
Formycon AG
FYB.F
DE
|
€19.86 22.93 USD |
-1.19
|
€350.98M 405.15M USD | €250.00 288.58 USD | €19.52 22.53 USD | €19.86 22.93 USD | €350.98M 405.15M USD | 0 | -€3.66 -4.2 USD | ||
|
Autolus Therapeutics plc
6A3A.F
DE
|
€1.27 1.47 USD |
0
|
€338.00M 390.17M USD | €21.99K 25.38K USD | €1.27 1.47 USD | €1.27 1.47 USD | €338.00M 390.17M USD | 0 | -€0.95 -1.09 USD | ||
|
Editas Medicine, Inc.
8EM.F
DE
|
€2.18 2.52 USD |
-3.11
|
€334.55M 386.18M USD | €2.00K 2.31K USD | €2.18 2.52 USD | €2.18 2.52 USD | €334.55M 386.18M USD | 0 | -€0.99 -1.1 USD | ||
|
Flerie AB (publ)
1NP.F
DE
|
€4.16 4.8 USD |
+1.96
|
€325.60M 375.86M USD | €1.00 1.15 USD | €4.03 4.65 USD | €4.14 4.78 USD | €325.60M 375.86M USD | 0 | -€8.83 -10.1 USD | ||
|
お気に入り銘柄なし
お気に入りの株式はまだありません。ここで表示するにはお気に入りに追加してください |
|||||||||||